PUBLIC COMPANY
saveADARx Pharmaceuticals Inc
founded 2019 · 125 employees · San Diego, CA, USupdated 1mo ago
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing next-generation RNA-targeted therapeutics, including siRNA, antisense, and proprietary RNA editing (EditR) platforms. Its pipeline spans genetic, cardiometabolic, complement-mediated, and central nervous system diseases, with lead programs ADX-324 (hereditary angioedema) and ADX-038 in clinical development.
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that